Table 3.
Groups | Excitement signs (initiation; duration) | Congestion of conjunctiva (initiation; duration) | Rigidity of four limbs (initiation; duration) | Emesis (initiation) | Muscle tremors (initiation; duration) |
Control | 0/8* | 0/8 | 0/8 | 3/8 (148, 158, 189) | 0/8 |
ATI | 2/8 (68±11; 83±32)† | 1/8 (90; 30) | 4/8 (53±19; 41±26) | 0/8 | 0/8 |
FLU | 0/8 | 0/8 | 1/8 (75; 15) | 3/8 (187, 212, 214) | 0/8 |
4AP | 1/8 (120; 30) | 0/8 | 2/8 (135±21; 25±7) | 2/8 (144, 202) | 0/8 |
ATI–FLU | 3/8 (110±17; 80±35) | 0/8 | 4/8 (34±14; 40±41) | 0/8 | 0/8 |
FLU–4AP | 0/8 | 0/8 | 0/8 | 1/8 (140) | 0/8 |
ATI–4AP | 3/8 (60±26; 62±15) | 2/8 (68±32; 23±11) | 3/8 (37±28; 33±24) | 0/8 | 4/8 (71±38; 49±43) |
ATI–FLU–4AP | 7/8 (74±36; 35±27) | 3/8 (70±9; 25±17) | 6/8 (7±4; 62±69) | 0/8 | 5/8 (52±34; 27±20) |
Positive/examined cats.
Time (mean±SD, min) after injection of potential antagonists in positive cats.